Merlin Biotech Inc.
Doylestown, PA
- UEI
- U33SZN8R3966
- CAGE
- 9K6A1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3805 Old Easton Rd ofc 2209, Doylestown, PA 18902, USA
- Website
- merlinbiotech.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$55,000 |
| FY2025 | $355,000 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir FY25 concept award, development of an immunotherapy for ewing sarcoma using a novel murine model | National Cancer Institute (NIH) | $300,000 |
Quick answers
Is Merlin Biotech Inc. registered in SAM.gov?
Yes. Merlin Biotech Inc.'s SAM.gov registration is active through February 6, 2027.
How much has Merlin Biotech Inc. received in federal contracts?
Federal contracts obligated $355,000 to Merlin Biotech Inc. in fiscal year 2025 and $300,000 in fiscal years 2023 through 2027.
What is Merlin Biotech Inc.'s most recent federal award?
Merlin Biotech Inc.'s most recent federal contract award is Sbir FY25 concept award, development of an immunotherapy for ewing sarcoma using a novel murine model (75N91025C00025), from National Cancer Institute (NIH), on September 22, 2025.
On GovTribe
See Merlin Biotech Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors